Your browser doesn't support javascript.
loading
Use of palivizumab is underestimated in the Swedish Prescribed Drug Register - implications for register-based drug studies.
Linder, Marie; Byström, Camilla; Kieler, Helle; Bergman, Gunnar; Haerskjold, Ann.
Affiliation
  • Linder M; Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Byström C; Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Kieler H; Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Solna, Stockholm, Sweden.
  • Bergman G; Stockholm-Uppsala Department of Pediatric Cardiology, Astrid Lindgren Children's Hospital, Karolinska University Hospital and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Haerskjold A; Child and Adolescent Clinic, Pediatric Department, Copenhagen University Hospital, Rigshospitalet Hospital, Copenhagen, Denmark ; Research Unit Women's and Children's Health, the Juliane Marie Centre for Women, Children and Reproduction, Copenhagen University Hospital, Rigshospitalet Hospital, Copen
Clin Epidemiol ; 7: 45-51, 2015.
Article in En | MEDLINE | ID: mdl-25565893
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Epidemiol Year: 2015 Document type: Article Affiliation country: Sweden Country of publication: New Zealand
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Clin Epidemiol Year: 2015 Document type: Article Affiliation country: Sweden Country of publication: New Zealand